(HealthDay)—The first implantable device for adults with a severe or profound form of a condition called "sensorineural hearing loss" has been approved by the U.S. Food and Drug Administration.
Mar 20, 2014
(HealthDay)—Impavido (miltefosine) has been approved by the U.S. Food and Drug Administration to treat adults with leishmaniasis, a tropical disease caused by a parasite that's transmitted by the bites of sand flies.
Mar 20, 2014
The decision to initiate dialysis for acute kidney injury (AKI) varies depending on different patient factors and there is a lack of robust evidence as to which patients are likely to benefit most and why. A new study from ...
Mar 20, 2014
States with broader Medicaid coverage have lower incidences of kidney failure and smaller insurance-related gaps in access to kidney disease care. Those are the findings of a study appearing in an upcoming issue of the Journal ...
Mar 20, 2014
